#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras

Managing antimicrobial resistance (AMR) will require innovative
solutions from many different disciplines. Could
pharmacovigilance be one of them? Jean Marie Vianney Habarugira
and Albert Figueras, who have been investigating how drug safety
tools could help track AMR, think it’s time the two communities
joined forces for good.

Tune in to find out:


How to code adverse drug reactions for optimal AMR
surveillance

How to use pharmacovigilance networks to track resistant
pathogens and falsified antimicrobials

Why collaborating with AMR specialists will benefit the drug
safety community



Want to know more?


In their study, Jean Marie and Albert shortlisted 17 MedDRA
codes used to report AMR-related adverse drug reactions in a
global and a national pharmacovigilance database.

Pharmacovigilance tools could be especially useful in
estimating the burden of AMR in low-resource communities that
lack diagnostic lab capacity.

Jean Marie’s research was inspired by this article in Uppsala
Reports, which defined antimicrobial resistance as an overlooked
adverse event.

Since 2015, the World Health Organization’s GLASS (Global
Antimicrobial Resistance and Use Surveillance System) has been
used to collect, analyse, and share AMR data around the world.



Interested in AMR from a social perspective? Then don’t miss this
Drug Safety Matters episode on behaviour change communication.





Join the conversation on social mediaFollow us on
Facebook, LinkedIn, X, or Bluesky and share your thoughts about
the show with the hashtag #DrugSafetyMatters.

Got a story to share?We’re always looking for new
content and interesting people to interview. If you have a great
idea for a show, get in touch!

About UMCRead more about Uppsala Monitoring Centre
and how we work to advance medicines safety.